Skip to main content
. 2021 Jun 14;22(12):6360. doi: 10.3390/ijms22126360

Table 4.

New Eurofever/PRINTO Classification Criteria for TRAPS.

Presence of pathogenic TNFRSF1A mutations and at least one among the following:
▪ Duration of episodes ≥ 7 days
▪ Myalgia
▪ Migratory rash
▪ Periorbital oedema
▪ Relatives affected
OR Presence of VUS of TNFRSF1A and at least two among the following:
▪ Duration of episodes ≥ 7 days
▪ Myalgia
▪ Migratory rash
▪ Periorbital oedema
▪ Relatives affected